Track the 에스엘에스바이오 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 에스엘에스바이오 has logged 22 insider filings. Market capitalisation: €29.6bn. The latest transaction was reported on 10 March 2026 (Other). Among the most active insiders: 문해란. All data is accessible without an account.
22
Insider Decl.
0
Thresholds
·
8 ops.
Buy Volume
·
0 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 25,911 of 26,270 companies
8.1
score / 100
Value
13
Quality
3
FCF yld-13%
Earn yld-17%
EV/EBITDA·
ROE-59%
Gross mgn-49%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.